Delivery Order SPE2DE24D0013-SPE2D626F5274
- Not listed
- The Defense Logistics Agency (DLA), under the Medical Supply Chain program, awarded a delivery order valued at $1,648.38 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on August 12, 2025. This firm fixed-price delivery order, without set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic testing solutions to federal defense and healthcare agencies. The contract is scheduled for ultimate completion by August 19, 2025,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated 4569773284 under the contract vehicle GXCT/NG-10, represents work to be performed at Cepheid's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a firm fixed-price delivery order valued at $3,708.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation. This award represents a discrete delivery order under one of Cepheid's larger indefinite delivery vehicle contracts with the...
- The Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $4,791.90 to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, identified as 4568960199 / GXCT/NG-10, carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a discrete purchase of molecular diagnostic solutions from Cepheid, a leading manufacturer of advanced...
- The Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a $6,210.28 firm fixed-price delivery order to Cepheid Inc. on September 11, 2025, with an ultimate completion date of September 18, 2025. This contract carries no set-aside designation and represents a delivery order under a larger indefinite delivery vehicle (IDV) contract structure. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, is the prime contractor and...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $27,650.40 firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with completion targeted for September 25, 2025. The delivery order, identified as XPRSMVP-10 (Contract Number 4569505244), is being performed at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents a discrete procurement under the company's broader federal contracting relationship with...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a firm fixed-price delivery order valued at $1,190.28 from the Defense Logistics Agency (DLA), which operates under the Medical Supply Chain function. The contract, awarded on September 11, 2025, with an ultimate completion date of September 25, 2025, carries no set-aside designation. This delivery order is executed under a larger indefinite delivery vehicle (IDV) contract structure, enabling...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,880.04 by the Defense Logistics Agency Medical Supply Chain on October 17, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, is scheduled for completion by October 24, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as a...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $5,520 firm fixed-price delivery order to Cepheid Inc. on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order, designated XPRSTREPA-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The contract represents a procurement of molecular diagnostic solutions from Cepheid, a specialized manufacturer of advanced...
- The Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $3,081.60 to Cepheid Inc. on August 7, 2025, for molecular diagnostic solutions. This firm fixed-price delivery order, designated 4569021301 and classified as GXCDIFF/EPI-10, is scheduled for completion by August 21, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The award carries no set-aside designation and represents a continuation of the federal...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F5274Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a Delivery Order (Contract No. GXCARBAR-10) valued at $2,039.40 to Cepheid Inc. on October 27, 2025, with ultimate completion by November 3, 2025. This firm fixed-price delivery order, which includes no set-aside designation, represents a task order issued under Cepheid's existing Indefinite Delivery Contract with the DLA Medical Supply Chain. Cepheid, headquartered in Sunnyvale, California, is a manufacturer of advanced molecular diagnostic systems and reagents specializing in infectious disease detection. The company serves as a primary federal supplier of diagnostic solutions, with particular expertise in GeneXpert diagnostic platform technologies and associated molecular testing capabilities for conditions including COVID-19, influenza, respiratory syncytial virus, MRSA, tuberculosis, and sexually transmitted infections. This delivery order falls within the scope of Cepheid's extensive federal contracting relationships across multiple healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. Cepheid holds significant Indefinite Delivery Contracts with the VA, including a $32.8 million contract with VISN 6 extending through September 2030 for molecular diagnostic testing system reagents and assays. The DLA Medical Supply Chain delivery order supports the federal government's ongoing procurement of diagnostic testing supplies and reagents necessary for military medical operations and defense healthcare missions. Performance will occur at Cepheid's facility in Sunnyvale, California.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/27/25 |